Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Crupi

Showing results (11-20 of 37) with videos related to

Pageof 4
Sort By:
Endocrine-Related Cancer|November 23, 2016
Differential roles of RET isoforms in medullary and papillary thyroid carcinomasEric Y Lian, Sarah M Maritan, Jessica G Cockburn, et al.
Nanomaterials (Basel, Switzerland)|April 3, 2021
A High-Throughput NanoBiT-Based Serological Assay Detects SARS-CoV-2 SeroconversionTaha Azad, Reza Rezaei, Ragunath Singaravelu, et al.
Journal of Cell Science|August 11, 2017
Differential recruitment of E3 ubiquitin ligase complexes regulates RET isoform internalizationBrandy D Hyndman, Mathieu J F Crupi, Susan Peng, et al.
Journal for Immunotherapy of Cancer|June 21, 2018
Enhanced susceptibility of cancer cells to oncolytic rhabdo-virotherapy by expression of Nodamura virus protein B2 as a suppressor of RNA interferenceDonald Bastin, Amelia S Aitken, Adrian Pelin, et al.
Oncogene|October 25, 2019
GGA3-mediated recycling of the RET receptor tyrosine kinase contributes to cell migration and invasionMathieu J F Crupi, Sarah M Maritan, Eduardo Reyes-Alvarez, et al.
ACS Nanoscience Au|August 14, 2023
Luciferase-Based Biosensors in the Era of the COVID-19 PandemicTaha Azad, Helena J Janse van Rensburg, Jessica Morgan, et al.
Scientific Reports|November 16, 2024
High throughput screen identifies lysosomal acid phosphatase 2 (ACP2) to regulate IFN-1 responses to potentiate oncolytic VSV∆51 activityBoaz Wong, Rayanna Birtch, Anabel Bergeron, et al.
Frontiers in Immunology|May 8, 2023
Syngeneic mouse model of human HER2+ metastatic breast cancer for the evaluation of trastuzumab emtansine combined with oncolytic rhabdovirusZaid Taha, Mathieu J F Crupi, Nouf Alluqmani, et al.
Biorxiv : the Preprint Server for Biology|July 10, 2023
Loss of Tumour Suppressor TMEM127 Drives RET-mediated Transformation Through Disrupted Membrane DynamicsTimothy J Walker, Eduardo Reyes-Alvarez, Brandy D Hyndman, et al.
Journal for Immunotherapy of Cancer|January 22, 2026
Oncolytic vaccinia virus encoding constitutively active EPAC remodels the tumor microenvironment to enhance therapeutic efficacy with chemotherapy and surgeryStephen Boulton, Siddharth Singh, Bailey Organ, et al.
Pageof 4

Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
Endocrine-Related Cancer|November 23, 2016
Differential roles of RET isoforms in medullary and papillary thyroid carcinomasEric Y Lian, Sarah M Maritan, Jessica G Cockburn, et al.
Nanomaterials (Basel, Switzerland)|April 3, 2021
A High-Throughput NanoBiT-Based Serological Assay Detects SARS-CoV-2 SeroconversionTaha Azad, Reza Rezaei, Ragunath Singaravelu, et al.
Journal of Cell Science|August 11, 2017
Differential recruitment of E3 ubiquitin ligase complexes regulates RET isoform internalizationBrandy D Hyndman, Mathieu J F Crupi, Susan Peng, et al.
Journal for Immunotherapy of Cancer|June 21, 2018
Enhanced susceptibility of cancer cells to oncolytic rhabdo-virotherapy by expression of Nodamura virus protein B2 as a suppressor of RNA interferenceDonald Bastin, Amelia S Aitken, Adrian Pelin, et al.
Oncogene|October 25, 2019
GGA3-mediated recycling of the RET receptor tyrosine kinase contributes to cell migration and invasionMathieu J F Crupi, Sarah M Maritan, Eduardo Reyes-Alvarez, et al.
ACS Nanoscience Au|August 14, 2023
Luciferase-Based Biosensors in the Era of the COVID-19 PandemicTaha Azad, Helena J Janse van Rensburg, Jessica Morgan, et al.
Scientific Reports|November 16, 2024
High throughput screen identifies lysosomal acid phosphatase 2 (ACP2) to regulate IFN-1 responses to potentiate oncolytic VSV∆51 activityBoaz Wong, Rayanna Birtch, Anabel Bergeron, et al.
Frontiers in Immunology|May 8, 2023
Syngeneic mouse model of human HER2+ metastatic breast cancer for the evaluation of trastuzumab emtansine combined with oncolytic rhabdovirusZaid Taha, Mathieu J F Crupi, Nouf Alluqmani, et al.
Biorxiv : the Preprint Server for Biology|July 10, 2023
Loss of Tumour Suppressor TMEM127 Drives RET-mediated Transformation Through Disrupted Membrane DynamicsTimothy J Walker, Eduardo Reyes-Alvarez, Brandy D Hyndman, et al.
Journal for Immunotherapy of Cancer|January 22, 2026
Oncolytic vaccinia virus encoding constitutively active EPAC remodels the tumor microenvironment to enhance therapeutic efficacy with chemotherapy and surgeryStephen Boulton, Siddharth Singh, Bailey Organ, et al.
Pageof 4